BDBM696728 (R) or (S) N-(5-((R)- 3-(2-hydroxypropan-2- yl)pyrrolidin-1-yl)-2- (trifluoromethyl)pyridin-3- yl)-6-(1-(1,1,1-trifluoro- propan-2-yl)-1H-pyrazol- 4-yl)picolinamide::US20240308980, Ex-3.1::US20240308980, Ex-3.2

SMILES CC(n1cc(cn1)-c1cccc(n1)C(=O)Nc1cc(cnc1C(F)(F)F)N1CC[C@H](C1)C(C)(C)O)C(F)(F)F

InChI Key InChIKey=FCULTJCRKDZPCC-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 696728   

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM696728(US20240308980, Ex-3.1 | US20240308980, Ex-3.2 | (R...)
Affinity DataIC50: 1.43E+3nMAssay Description:Compound potency against LRRK2 kinase activity was determined using LanthaScreen technology from Life Technologies Corporation (Carlsbad, CA) using a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM696728(US20240308980, Ex-3.1 | US20240308980, Ex-3.2 | (R...)
Affinity DataIC50: 5.87E+4nMAssay Description:Compound potency against LRRK2 kinase activity was determined using LanthaScreen technology from Life Technologies Corporation (Carlsbad, CA) using a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
US Patent